rfhg_209800.1

Basic information about the TSS

---

TSS ID: rfhg_209800.1 Species: human Chr: chr19		Start: 19192811 End: 19192842 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3049096,EH38E1945071)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000540981.5:0 GeneID: 8625 HGNC/MGI_ID: HGNC:9987 UniProt_ID: F5GY33 Nearer transcript ids and distances: ENST00000543157.7:4 ENST00000407360.7:-48 ENST00000392324.8:69 ENST00000541873.6:71 NM_001278728.2:93 NM_001370236.1:93 NM_001370237.1:93 NM_001370234.1:93 NM_001370233.1:93 NM_001370238.1:93 AF105427:105 AF077196:113 AF105428:122 ENST00000545522.2:128 view more...

Gene_name: RFXANK Gene_symbol: RFXANK Gene_synonyms: ANKRA1 BLS F14150_1 MGC138628 RFX-B Gene_source: HGNC:9987

TATA-Box annotation

---

Distance to TSS:	60
Nearest PromoterID:	NM_001278728
Entrez ID:	8625
Nearest Unigene:	Hs.153629
Nearest Refseq:	NM_003721
Nearest Ensembl:	ENSG00000064490
Gene Name:	RFXANK
Gene Alias:	ANKRA1|BLS|F14150_1|RFX-B
Gene Type:	protein-coding
CpG%:	0.032258
GC%:	0.593750
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):	15(TCTTAAAGGGCC,+,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RFXANK p2@RFXANK p3@RFXANK p5@RFXANK
Sample		p1@RFXANK	p2@RFXANK	p3@RFXANK	p5@RFXANK
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	18.51	4.48	1.56	0.97
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	19.42	6.88	0.81	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	17.75	4.44	1.74	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	15.80	5.41	1.87	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	17.55	6.52	1.12	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	16.86	5.62	2.13	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	27.89	9.37	3.05	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	22.53	7.27	2.66	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	23.30	9.19	1.07	1.71
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	24.34	6.96	6.38	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	23.04	12.94	4.04	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	27.24	7.32	3.25	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	31.43	1.29	1.29	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	32.17	0.75	2.41	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	36.88	0.44	1.54	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	26.16	0.50	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	27.52	0.44	0.66	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	34.17	0.42	1.27	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	31.99	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	37.01	1.65	1.35	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	35.15	0.53	1.87	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	35.39	0.35	2.07	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	29.21	0.90	0.78	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	28.88	0.24	1.21	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	32.25	0.26	2.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	40.83	2.22	2.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	32.42	1.10	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	40.79	0.94	1.41	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	36.50	0.32	2.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	28.77	1.81	1.45	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	35.80	0.21	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	32.24	0.39	1.17	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	33.98	0.21	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	48.33	1.15	0.99	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	33.47	0.00	1.68	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	28.94	0.19	1.15	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	32.09	0.41	1.23	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	29.62	0.40	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	31.87	0.54	0.54	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	30.73	0.48	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	28.70	0.94	1.41	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	35.87	0.59	1.32	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	37.54	0.63	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	34.27	0.52	1.22	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	36.54	0.80	1.41	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	41.41	0.93	0.70	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	43.42	0.72	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	42.92	0.30	1.49	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	39.50	0.24	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	39.43	0.00	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	40.17	0.00	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	42.03	0.44	0.89	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	33.00	0.00	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	29.49	0.99	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	41.11	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	49.14	0.00	2.30	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	38.57	0.00	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	30.51	0.00	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	55.01	0.31	0.31	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	32.43	0.71	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	35.33	1.68	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	46.97	1.59	0.00	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	43.15	1.02	1.02	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	29.89	0.65	0.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	23.07	0.71	1.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	18.04	0.98	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	28.76	0.99	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.52	0.94	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	29.81	1.66	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	25.68	0.93	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	18.96	1.22	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	13.78	0.32	0.63	0.48
Adipocyte - breast, donor2	11327-117E4	12.83	1.28	0.48	0.32
Adipocyte - omental, donor1	11473-119C6	18.58	1.78	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	12.71	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	14.40	1.67	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	14.67	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.00	1.81	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	10.95	5.04	1.56	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	21.12	2.54	1.17	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	24.71	2.57	0.51	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	18.96	5.30	1.39	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	21.75	2.35	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	11.74	1.93	1.13	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	13.88	2.58	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	1.07	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	8.90	2.23	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.49	2.50	1.66	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	7.28	3.27	0.75	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	9.16	2.95	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	7.31	2.13	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	42.87	2.87	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	60.60	7.53	0.72	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	10.78	3.59	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	17.63	5.22	2.34	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	21.76	6.69	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	13.35	5.14	1.44	0.00
Anulus Pulposus Cell, donor1	11248-116E6	39.25	3.55	2.06	0.34
Anulus Pulposus Cell, donor2	11463-119B5	26.45	2.69	0.98	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	23.36	1.80	1.80	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	23.44	0.43	1.74	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	23.54	0.00	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	22.72	0.60	0.60	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	25.08	1.32	1.98	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	21.44	0.65	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	24.76	0.97	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	24.35	1.78	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	26.74	1.13	2.26	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.77	2.18	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	23.82	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	31.96	2.14	0.33	0.82
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	26.84	2.26	1.51	1.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	19.29	1.61	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	25.88	1.32	0.57	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	25.39	1.34	1.07	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	0.00	2.93	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	20.73	1.00	1.00	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	21.61	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	0.00	3.54	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	19.38	1.20	0.69	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	22.81	0.49	0.97	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	22.01	0.00	0.38	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	29.07	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	24.51	0.57	0.00	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	17.32	1.50	0.86	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.52	0.52	1.81	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	25.81	1.41	3.75	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	16.08	1.61	0.32	2.25
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	24.26	2.85	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.98	0.00	2.34	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	16.56	3.31	0.90	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	26.14	1.19	2.38	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	25.94	1.53	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	28.02	1.53	1.78	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	24.78	1.91	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	20.28	0.43	1.29	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	21.38	1.69	2.33	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	22.62	1.16	2.03	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	21.87	1.53	0.68	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	25.35	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	19.30	0.43	0.86	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.68	1.80	1.80	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	28.43	1.46	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	23.68	2.53	1.38	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	26.19	1.02	2.29	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	28.28	1.45	0.83	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	21.42	0.61	1.22	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	24.86	0.96	1.43	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	22.62	1.55	1.33	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	28.99	1.53	6.10	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	36.00	1.66	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	23.04	0.79	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	17.45	0.73	0.73	2.18
Astrocyte - cerebellum, donor1	11500-119F6	50.48	4.05	1.35	1.23
Astrocyte - cerebellum, donor2	11580-120F5	46.04	3.42	1.20	1.37
Astrocyte - cerebellum, donor3	11661-122F5	53.70	3.78	2.52	1.68
Astrocyte - cerebral cortex, donor1	11235-116D2	39.39	4.18	2.09	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	33.33	4.69	0.65	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	34.16	4.92	1.04	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	23.40	2.64	3.33	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	25.93	1.25	3.01	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	24.12	2.16	2.05	0.23
Basophils, donor1	12241-129G9	5.75	3.92	3.14	0.00
Basophils, donor2	12242-129H1	7.58	8.66	4.33	0.00
Basophils, donor3	12243-129H2	4.85	5.29	4.70	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	16.60	4.74	0.86	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	45.72	7.31	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	56.49	3.77	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	50.32	2.70	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	45.14	4.15	2.07	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	13.50	3.60	0.72	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	29.58	0.82	2.78	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	43.09	1.16	0.70	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	52.76	2.24	3.52	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	2.82	5.07	2.25	0.00
CD14+ Monocytes, donor2	11305-117B9	3.16	3.90	0.93	0.00
CD14+ Monocytes, donor3	11381-118B4	4.39	5.27	2.63	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	12.17	3.96	1.13	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	10.24	6.07	1.52	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	11.18	3.29	1.64	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	3.18	1.73	2.60	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	3.62	0.30	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	2.84	0.71	1.90	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.01	1.34	1.67	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2.21	0.28	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	1.74	0.25	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.55	1.37	0.98	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.03	0.89	1.60	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	6.09	0.87	2.83	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.98	0.70	1.40	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.64	1.06	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1.11	0.00	4.44	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	2.97	2.23	2.23	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2.79	0.20	0.80	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2.71	1.04	2.08	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	4.12	1.83	1.37	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	2.49	0.68	1.58	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1.75	0.87	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	2.69	2.42	1.61	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3.14	1.22	2.62	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	2.95	0.00	2.10	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.12	0.92	2.02	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.41	0.70	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1.75	0.44	1.32	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	3.31	1.22	1.57	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2.97	0.74	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	4.74	1.08	2.59	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.69	0.82	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.39	1.16	1.62	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	3.02	0.46	1.16	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	6.76	5.23	3.27	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	8.78	9.93	3.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	8.23	5.85	2.82	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	9.34	5.14	3.43	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	6.99	4.54	4.37	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	8.25	4.68	2.23	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	5.61	6.63	4.85	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	4.61	5.49	3.95	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	4.21	8.21	4.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	22.36	0.00	6.10	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	31.86	4.75	4.75	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	33.14	8.28	9.32	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	25.59	7.46	11.73	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	23.59	9.65	9.65	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	40.71	3.51	7.72	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	27.45	7.84	8.63	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	34.28	11.86	7.91	0.00
CD19+ B Cells, donor1	11544-120B5	9.04	2.47	9.04	0.00
CD19+ B Cells, donor2	11624-122B4	4.35	3.63	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	6.06	4.54	3.03	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	11.31	22.63	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	10.79	24.37	0.80	0.40
CD34+ Progenitors, donor1	11545-120B6	26.11	1.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	16.29	3.37	3.37	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	49.98	1.88	3.01	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	57.50	5.86	2.71	1.58
CD4+ T Cells, donor1	11225-116C1	4.64	6.78	7.14	0.00
CD4+ T Cells, donor2	11306-117C1	3.67	9.80	6.74	0.00
CD4+ T Cells, donor3	11382-118B5	3.05	5.79	4.27	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	17.87	11.49	4.34	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	22.01	8.09	4.72	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	21.56	13.51	5.75	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	18.02	6.16	6.16	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	11.94	7.02	4.21	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	3.30	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	32.52	6.36	3.32	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	23.72	5.76	5.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	24.50	7.58	3.39	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	20.17	7.62	6.28	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	14.32	4.89	5.94	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	10.56	3.08	5.28	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	21.50	5.48	3.79	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	20.57	4.78	4.78	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	26.40	7.35	4.68	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	19.04	7.07	6.53	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	18.22	4.82	6.43	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	8.97	7.17	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	29.11	10.01	5.38	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	19.06	6.72	6.93	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	20.38	11.35	6.30	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	21.24	4.04	6.07	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	20.80	9.10	6.07	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	9.59	9.15	6.54	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	32.17	14.35	8.41	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	30.47	10.16	2.77	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	16.75	8.37	13.96	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	20.22	11.08	6.09	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	15.21	17.18	4.17	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	18.48	10.78	4.62	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	22.92	15.76	5.37	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	33.24	18.00	5.54	0.00
CD8+ T Cells, donor1	11226-116C2	7.20	4.91	4.26	0.00
CD8+ T Cells, donor2	11307-117C2	8.63	7.51	6.01	0.00
CD8+ T Cells, donor3	11383-118B6	9.34	3.79	6.06	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	9.41	3.44	3.21	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	12.70	3.35	2.40	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	12.59	3.56	4.38	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	16.21	5.70	2.70	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.48	2.16	2.16	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	8.64	2.05	2.96	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	11.08	3.04	2.39	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	13.42	2.37	3.16	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	12.90	5.86	2.35	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	16.30	4.83	3.02	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	19.17	2.91	2.32	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	18.92	3.73	2.40	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.07	4.82	3.06	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.93	0.46	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	10.44	2.24	2.98	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	12.97	3.96	2.16	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	13.52	3.74	3.74	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.25	3.77	1.89	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	15.85	6.34	2.85	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	10.15	5.54	1.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	17.31	4.17	1.92	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	19.12	3.44	1.91	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.79	5.91	1.58	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	15.88	1.51	3.78	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	13.65	6.42	4.01	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	11.19	6.29	2.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	16.03	3.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	16.45	5.48	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	25.20	4.45	1.98	0.99
Cardiac Myocyte, donor3	11686-122I3	30.62	2.63	0.84	0.11
Chondrocyte - de diff, donor1	11261-116G1	15.25	1.04	1.04	0.69
Chondrocyte - de diff, donor2	11338-117F6	14.57	1.07	1.42	0.00
Chondrocyte - de diff, donor3	11410-118E6	16.95	2.39	2.16	0.00
Chondrocyte - re diff, donor2	11339-117F7	33.12	1.79	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	12.94	2.02	1.21	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	42.92	5.16	1.38	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	45.10	3.21	1.07	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	38.14	2.21	0.97	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	12.84	3.58	2.29	0.09
Corneal Epithelial Cells, donor1	11526-119I5	27.45	4.39	0.88	0.44
Corneal Epithelial Cells, donor2	11606-120I4	25.03	4.55	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	22.75	4.35	1.28	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	11.39	2.81	1.16	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	8.20	4.42	1.58	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.99	2.48	1.30	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	13.67	4.78	4.44	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	24.81	4.57	5.88	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	15.00	4.36	7.26	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	23.68	3.00	3.84	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	29.34	1.76	0.59	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	37.33	3.96	1.98	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	29.10	3.54	2.36	1.18
Endothelial Cells - Artery, donor1	11264-116G4	37.52	2.33	1.75	2.62
Endothelial Cells - Artery, donor2	11341-117F9	48.00	4.00	1.65	1.65
Endothelial Cells - Artery, donor3	11413-118E9	34.01	4.38	1.75	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	22.83	2.88	1.99	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	21.60	1.52	3.04	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	20.02	1.69	2.26	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	24.36	4.46	2.67	1.49
Endothelial Cells - Microvascular, donor2	11342-117G1	40.09	6.25	2.08	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	21.27	5.10	3.12	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	31.61	2.00	0.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	49.79	3.14	4.72	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	27.21	3.98	1.24	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	29.11	2.17	1.30	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	18.32	3.42	0.85	0.49
Endothelial Cells - Vein, donor1	11267-116G7	53.46	4.55	3.41	2.28
Endothelial Cells - Vein, donor2	11344-117G3	50.29	7.68	4.19	2.79
Endothelial Cells - Vein, donor3	11416-118F3	36.90	4.55	2.04	1.26
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	1.65	13.20	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	10.70	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	30.05	1.95	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	8.32	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.53	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	18.72	1.31	0.22	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	32.50	3.79	0.87	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	25.47	0.97	0.73	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	27.98	1.77	1.91	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	24.36	0.95	0.95	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	21.61	1.32	1.05	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	13.95	1.33	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	30.39	1.36	1.81	0.45
Fibroblast - Cardiac, donor2	11345-117G4	36.38	3.79	1.52	1.52
Fibroblast - Cardiac, donor3	11417-118F4	28.39	2.84	1.42	1.26
Fibroblast - Cardiac, donor4	11452-119A3	11.52	0.61	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	22.59	4.57	1.52	0.89
Fibroblast - Cardiac, donor6	11460-119B2	16.68	2.27	0.45	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	33.23	2.28	0.94	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	26.75	2.16	1.73	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	41.01	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	68.27	5.30	2.54	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	23.58	3.22	2.88	0.51
Fibroblast - Dermal, donor1	11269-116G9	20.90	1.64	1.88	0.70
Fibroblast - Dermal, donor2	11346-117G5	31.60	3.30	1.89	1.42
Fibroblast - Dermal, donor3	11418-118F5	19.58	2.42	1.45	0.12
Fibroblast - Dermal, donor4	11450-119A1	18.31	3.05	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	22.50	1.92	1.40	0.17
Fibroblast - Dermal, donor6	11458-119A9	20.47	1.95	0.65	0.16
Fibroblast - Gingival, donor1	11237-116D4	17.91	2.29	1.04	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	25.68	1.83	1.05	0.52
Fibroblast - Gingival, donor2	11318-117D4	34.53	2.24	0.40	0.40
Fibroblast - Gingival, donor3	11394-118C8	30.17	1.93	1.16	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	23.89	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	18.15	1.23	0.53	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	33.21	1.25	0.78	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	26.64	1.08	1.08	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	21.88	1.76	0.00	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	25.15	2.34	1.02	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	21.82	2.05	0.68	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	27.31	1.86	0.22	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	31.84	1.47	2.05	0.15
Fibroblast - Lung, donor1	11270-116H1	58.45	2.72	2.72	1.36
Fibroblast - Lung, donor2	11347-117G6	19.40	2.98	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	54.66	4.01	2.74	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	45.82	4.17	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	1.40	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	35.54	1.68	0.56	1.40
Fibroblast - Mammary, donor1	11540-120B1	26.79	2.03	0.00	0.81
Fibroblast - Mammary, donor2	11620-122A9	35.95	3.99	7.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	25.99	2.72	0.39	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	23.51	2.43	0.76	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	18.36	0.31	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	16.41	2.29	1.14	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	28.08	0.54	1.35	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	19.95	1.74	0.93	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	26.20	3.65	0.88	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	34.95	2.84	0.61	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	26.73	2.67	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	45.07	1.58	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	18.46	1.59	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.41	1.60	1.24	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	19.71	1.97	1.58	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	20.46	2.11	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	18.35	1.19	0.86	0.65
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	28.09	2.53	1.77	0.51
Fibroblast - skin normal, donor1	11553-120C5	13.29	1.15	1.64	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	19.05	1.40	0.80	0.20
Fibroblast - skin normal, donor2	11561-120D4	21.80	1.81	0.70	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	29.01	1.51	0.60	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	21.29	1.33	1.08	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	22.22	2.05	1.71	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	18.06	0.66	1.31	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.71	0.96	0.32	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	28.00	0.84	0.17	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	36.38	1.88	0.47	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	4.36	1.74	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	27.04	3.47	1.39	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	22.64	0.52	1.56	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	28.36	0.26	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	60.48	9.19	3.83	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	81.04	8.93	1.28	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	57.91	8.27	5.13	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	71.42	12.41	6.62	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	60.05	4.57	1.14	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	37.25	5.94	3.57	2.18
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	54.72	12.42	7.14	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	65.23	6.20	4.24	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	51.30	4.42	2.65	4.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	32.65	3.82	1.27	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	34.60	4.19	1.72	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	32.50	2.95	2.42	2.15
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	30.11	4.21	0.74	1.36
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	28.93	3.74	1.38	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	20.53	4.88	1.83	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	32.86	8.21	2.28	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	30.77	5.11	2.24	1.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	19.02	5.90	1.09	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	35.75	10.34	2.95	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	39.26	10.97	2.07	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	21.90	7.60	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	32.26	9.28	2.42	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	34.27	7.46	2.21	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	25.89	8.25	1.42	1.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.03	10.30	2.08	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.96	11.44	1.88	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	27.88	7.75	1.99	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.12	8.07	2.25	1.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	30.22	7.96	1.84	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	31.15	9.90	2.06	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	37.47	6.46	2.19	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	29.18	8.34	1.67	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	23.37	10.58	3.31	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	33.58	8.86	2.71	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	29.50	7.94	1.78	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	23.73	11.55	1.28	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	26.44	4.93	1.33	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	20.56	6.49	1.27	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	19.77	10.03	3.04	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	29.06	6.59	1.99	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	24.37	8.56	1.98	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	21.32	10.10	1.68	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	23.79	3.70	1.39	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	24.07	6.42	1.34	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	22.64	5.97	1.53	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	29.92	3.89	1.17	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	22.50	5.69	2.17	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	32.45	6.27	3.13	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	24.78	5.48	1.97	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	11.90	2.98	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.68	3.96	1.58	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.28	2.02	2.42	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	15.76	5.34	2.54	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	38.22	2.79	1.19	2.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	33.59	2.77	1.23	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	46.44	2.86	1.43	1.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	58.21	7.20	3.44	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	53.40	11.87	2.83	3.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	37.36	4.15	0.92	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	54.45	7.42	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	53.77	8.12	1.93	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	48.13	17.65	1.60	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	50.43	5.22	3.48	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	47.19	8.79	3.58	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	37.06	11.94	1.24	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	37.47	11.75	3.36	2.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	35.95	9.81	3.92	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	52.85	7.55	2.52	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	50.57	10.50	2.86	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	40.08	15.62	3.40	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	75.17	12.53	4.18	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	45.82	14.32	1.72	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	43.81	12.14	1.48	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	66.07	6.78	1.69	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	72.07	7.46	2.07	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	59.60	10.13	3.22	2.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	53.82	7.69	2.31	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	48.24	9.45	0.65	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	43.47	7.36	2.68	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	48.93	8.48	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	57.51	6.50	2.05	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	40.11	7.55	1.89	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	55.52	10.86	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	48.83	9.16	4.58	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	50.65	6.38	2.79	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	58.71	8.88	1.97	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	64.92	7.08	1.18	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	49.01	10.50	1.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	32.04	6.58	2.19	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	45.78	5.93	3.39	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	48.95	4.18	1.79	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	62.11	7.76	0.97	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	47.93	3.42	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	34.10	2.49	1.25	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	37.11	4.50	2.25	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	12.05	3.49	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	12.53	2.92	3.76	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	30.17	3.48	0.58	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	28.70	3.54	1.35	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	22.98	2.96	0.91	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	26.67	3.94	1.20	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	29.23	3.01	0.43	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	21.96	2.80	0.65	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	28.64	4.36	0.75	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	25.56	3.77	0.86	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	31.08	4.16	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	32.46	2.80	1.68	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	34.19	3.90	1.30	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	39.66	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	34.57	2.12	1.76	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	36.33	2.18	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	29.20	2.80	1.05	0.17
Hepatocyte, donor1	11523-119I2	2.42	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	2.15	6.46	0.00	0.00
Hepatocyte, donor3	11684-122I1	3.68	3.07	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	43.73	5.87	3.26	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	26.39	1.75	0.52	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	24.15	1.92	0.96	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	165.56	9.55	15.92	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	106.80	6.68	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	243.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	123.21	5.54	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	82.59	12.51	10.01	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	213.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	130.71	12.81	12.81	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	100.56	18.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	155.94	12.99	8.12	9.75
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	113.38	6.67	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	83.50	10.89	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	116.47	5.29	6.62	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	127.49	11.09	2.22	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	73.34	5.24	5.24	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	139.20	8.82	3.15	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	100.53	12.37	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	133.08	10.34	3.88	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	104.65	11.27	8.05	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	107.53	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	128.75	8.96	7.33	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	132.66	12.17	7.14	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	118.95	8.84	3.21	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	97.87	4.62	4.62	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	30.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	102.90	4.72	2.83	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	110.65	8.16	5.44	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	94.70	8.61	4.30	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	148.64	11.43	7.62	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	102.67	10.84	4.46	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	114.83	12.76	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	142.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	137.81	5.00	3.57	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	129.41	13.27	6.64	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	125.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	93.52	6.17	4.01	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	124.68	8.78	3.51	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	100.58	15.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	121.00	8.34	4.17	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	121.72	22.13	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	103.74	6.48	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	99.40	11.34	3.49	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	116.99	27.00	6.75	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	118.48	13.94	6.97	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	128.01	24.54	5.33	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	128.85	11.08	4.16	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	173.83	2.85	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	149.11	10.12	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	121.01	24.20	15.13	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	111.76	37.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	91.99	26.43	5.29	0.00
Keratinocyte - epidermal, donor1	11272-116H3	26.76	2.12	0.57	0.41
Keratinocyte - epidermal, donor2	11349-117G8	42.17	2.93	2.34	0.00
Keratinocyte - epidermal, donor3	11421-118F8	30.20	1.99	0.47	0.28
Keratinocyte - oral, donor1	11251-116E9	29.97	5.22	0.91	0.11
Keratocytes, donor1	11527-119I6	94.21	6.53	2.06	0.69
Keratocytes, donor2	11607-120I5	24.61	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	22.53	2.37	1.19	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	30.20	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	27.56	4.84	1.50	0.69
Lens Epithelial Cells, donor3	11690-122I7	42.38	1.61	1.21	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	30.24	7.00	3.79	2.49
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	21.77	5.58	4.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	28.65	4.72	2.83	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	27.96	5.38	3.76	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	27.42	1.89	2.21	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	29.43	6.36	3.77	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	28.32	5.75	2.87	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	33.88	6.07	2.78	1.77
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	28.29	4.93	3.52	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	16.61	3.96	2.37	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	29.08	5.62	1.94	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	33.14	5.37	4.63	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	23.34	2.44	2.09	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	28.86	5.01	2.15	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	28.57	4.81	3.71	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	24.64	5.54	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	32.11	5.30	3.43	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	30.38	6.04	3.84	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	24.35	6.25	2.63	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	33.68	7.32	2.64	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	34.85	6.47	3.73	1.99
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	23.28	5.82	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	25.58	2.96	4.31	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	30.12	3.63	2.72	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	29.55	4.15	5.70	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	22.61	5.03	2.51	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	30.07	6.01	3.01	1.20
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	30.95	2.06	3.44	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	27.28	4.14	2.63	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	26.72	6.26	3.39	1.27
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	21.32	4.85	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	21.83	3.97	2.32	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	25.65	4.96	2.35	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	27.03	4.44	4.07	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	26.19	3.46	2.47	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	23.24	7.01	2.75	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	25.41	2.89	3.54	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	21.91	5.17	3.04	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	22.39	4.20	3.64	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	25.96	3.91	1.78	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	24.72	9.21	2.42	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	32.06	4.98	3.73	1.71
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	27.22	6.45	3.58	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	22.54	3.27	2.94	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	34.84	8.24	5.18	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	29.21	6.31	2.48	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	26.38	4.61	3.07	1.54
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	27.45	4.18	4.18	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	49.85	11.33	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	34.52	13.04	9.97	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	33.40	5.94	5.94	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	40.20	9.31	5.92	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	31.65	7.03	7.03	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	36.42	10.27	4.67	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	38.13	9.79	3.61	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	28.55	14.27	5.95	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	35.29	9.73	6.56	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	26.17	9.02	2.04	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	28.81	8.10	5.40	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	36.04	12.06	4.34	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	35.43	8.73	4.11	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	23.64	8.47	3.88	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	27.32	3.33	2.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	29.03	8.15	3.06	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	26.15	6.67	4.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	29.48	6.80	3.02	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	37.43	7.98	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	44.85	8.97	6.52	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	27.49	8.33	2.71	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	29.99	9.25	3.64	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	35.03	9.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	22.93	6.68	2.32	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	31.99	4.19	2.39	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	27.66	7.19	2.77	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	34.64	8.48	5.66	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	30.24	5.53	1.84	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	35.69	6.91	3.45	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	38.38	7.68	3.84	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	35.67	8.49	5.66	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	42.66	4.10	3.28	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	29.37	5.87	6.33	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	37.34	8.62	5.75	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	30.62	9.71	3.73	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	32.70	6.32	3.72	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	32.74	9.48	3.02	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	32.54	8.56	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	35.32	12.33	3.66	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	25.94	7.24	2.41	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	24.17	8.53	4.27	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	28.87	5.84	4.81	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	33.28	8.05	3.22	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	33.67	5.39	4.04	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	34.08	8.89	3.70	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	45.35	10.47	3.49	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	38.08	7.40	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	30.01	11.20	2.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	36.34	9.45	6.54	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	33.73	9.20	4.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	41.93	10.85	2.47	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	12.23	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	30.67	4.53	4.53	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	35.15	9.91	4.51	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	1.72	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	38.74	7.13	7.57	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	40.28	10.56	5.47	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	42.22	9.24	2.64	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	36.84	7.78	6.23	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	37.19	11.38	2.63	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	24.60	8.39	2.24	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	33.12	11.48	3.53	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	34.71	7.33	4.24	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	34.94	14.68	3.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	30.28	7.21	3.84	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	31.41	13.52	5.57	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	32.81	7.29	3.65	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	27.67	4.84	2.77	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	38.76	11.40	1.90	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	30.99	7.75	3.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	24.19	6.05	3.02	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	31.06	11.73	4.75	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	37.85	8.53	2.67	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	36.20	6.32	2.87	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	40.11	11.31	5.14	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	32.54	7.07	3.54	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	35.75	5.67	2.84	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	36.61	5.41	1.66	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	44.63	10.18	0.00	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	32.15	9.19	2.51	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	42.75	7.90	4.18	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	41.48	9.37	3.35	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	33.15	5.35	3.21	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	40.01	7.27	4.85	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	29.37	8.26	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	36.45	6.22	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	41.03	10.83	2.28	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	36.81	4.60	1.53	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	33.92	5.47	2.19	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	35.19	3.56	1.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	44.19	7.80	2.86	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	37.80	4.64	1.33	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	39.49	6.24	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	11.40	2.96	1.82	0.00
Macrophage - monocyte derived, donor2	11313-117C8	3.85	2.02	0.92	0.00
Macrophage - monocyte derived, donor3	11389-118C3	9.96	3.15	1.31	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	37.70	1.59	1.06	1.06
Mallassez-derived cells, donor2	11929-125I3	19.17	1.74	1.43	0.32
Mallassez-derived cells, donor3	11930-125I4	32.80	1.81	0.83	0.56
Mammary Epithelial Cell, donor1	11273-116H4	18.04	3.69	1.30	0.10
Mammary Epithelial Cell, donor2	11350-117G9	28.09	5.21	1.45	0.00
Mammary Epithelial Cell, donor3	11422-118F9	24.44	3.49	2.24	0.50
Mast cell - stimulated, donor1	11487-119E2	7.46	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	11.46	2.70	1.95	0.11
Mast cell, donor2	11565-120D8	15.16	4.75	2.67	0.00
Mast cell, donor3	11566-120D9	16.21	6.53	2.48	0.00
Mast cell, donor4	11567-120E1	12.41	4.79	3.72	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	10.53	3.55	1.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	19.85	2.92	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	23.40	4.70	1.49	0.00
Mast cell, expanded, donor8	11941-126A6	19.92	5.36	2.85	0.00
Melanocyte - dark, donor1	11502-119F8	33.53	4.97	1.89	1.69
Melanocyte - dark, donor2	11582-120F7	30.46	4.50	1.73	0.69
Melanocyte - dark, donor3	11663-122F7	14.13	4.35	1.23	0.00
Melanocyte - light, donor1	11274-116H5	12.22	4.94	2.12	0.00
Melanocyte - light, donor2	11351-117H1	27.98	7.51	3.41	0.68
Melanocyte - light, donor3	11423-118G1	9.54	5.20	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	17.28	5.52	0.83	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	29.85	3.50	1.08	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	23.84	2.95	0.80	0.27
Meningeal Cells, donor1	11493-119E8	28.66	2.48	0.50	0.74
Meningeal Cells, donor2	11573-120E7	31.25	3.96	0.88	0.88
Meningeal Cells, donor3	11654-122E7	23.64	4.48	0.98	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	51.33	3.71	1.43	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	26.06	0.50	1.31	1.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	43.37	5.26	10.51	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	34.01	5.23	3.92	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	31.57	2.15	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	28.80	0.42	0.64	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	24.63	1.51	1.01	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	40.43	3.30	0.66	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	50.41	4.38	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	44.40	1.84	0.82	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	30.89	1.52	0.97	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	39.77	1.12	1.12	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	28.03	2.37	0.79	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	41.54	3.26	1.19	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	39.70	9.34	7.01	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	31.38	1.92	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	26.94	4.25	1.06	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	24.71	2.50	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	37.74	4.35	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	29.70	0.00	0.27	0.53
Mesothelial Cells, donor2	12156-128G5	39.04	1.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	21.39	0.29	0.14	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	10.80	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	11.57	1.23	1.72	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7.95	1.47	1.47	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	5.58	0.31	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	7.05	2.07	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	11.51	2.00	1.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	7.91	1.40	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	4.88	2.24	1.22	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	10.30	1.58	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	3.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.46	2.66	1.90	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.00	2.33	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	5.07	2.09	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	11.74	1.68	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.53	0.75	1.51	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5.70	0.95	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.21	0.00	0.55	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	4.37	1.15	0.69	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	7.15	1.05	0.84	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.91	0.82	0.61	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	7.72	0.86	1.72	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.56	1.11	1.33	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.50	0.44	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.06	0.51	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.44	1.09	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6.18	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.13	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	8.40	1.20	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.01	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	13.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.92	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.23	2.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.69	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.46	0.71	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	11.78	1.40	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.90	1.25	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.91	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.33	1.21	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.60	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	1.85	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	11.95	0.57	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.75	1.24	0.41	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.11	1.55	1.04	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	14.16	0.86	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.07	0.64	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	7.47	1.07	1.33	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.47	0.90	1.20	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.46	0.99	1.41	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	12.74	1.59	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	14.59	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.51	1.14	1.52	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11.65	1.70	0.85	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	11.06	2.46	1.72	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.78	3.26	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.88	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	16.15	2.31	1.73	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	8.24	2.89	3.30	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.04	3.28	2.68	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	3.56	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	14.13	1.97	2.30	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	14.73	6.31	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	6.72	2.57	2.37	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	5.59	6.52	3.73	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	3.00	1.13	1.88	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	4.79	2.93	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	9.16	2.15	1.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	3.68	5.16	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	10.63	5.13	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	7.78	1.56	3.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.02	1.60	2.14	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	15.15	2.02	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	6.75	0.84	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.09	3.18	1.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.91	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	32.53	0.65	0.65	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	19.86	3.14	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	22.69	1.33	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	26.29	1.67	0.42	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	51.72	2.66	1.52	1.71
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	52.66	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	23.80	2.72	0.68	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.25	0.84	1.26	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	38.58	0.93	0.46	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	25.40	0.81	0.81	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.23	0.63	0.84	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	34.25	0.99	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	30.32	2.44	1.62	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	28.34	1.36	2.27	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	23.19	0.16	0.33	1.31
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	28.43	0.00	2.00	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	21.75	1.06	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.81	1.20	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	56.45	0.98	0.98	3.28
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.75	0.81	1.63	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	20.46	0.53	0.71	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	25.32	0.70	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	19.31	1.38	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	30.21	0.00	1.29	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	37.94	0.69	2.07	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	2.53	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	18.49	0.89	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	25.83	0.00	0.42	1.69
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	23.02	2.61	1.90	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	25.33	0.43	1.29	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	24.99	0.33	0.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	20.29	0.90	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	15.87	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	23.22	1.86	1.86	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	29.13	1.51	1.51	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	12.06	0.65	1.30	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	19.61	1.74	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.93	0.90	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	0.00	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	18.35	1.49	0.50	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	15.31	0.38	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	30.85	2.72	1.21	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	17.02	0.44	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.84	2.03	0.68	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	21.34	1.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	16.37	0.63	0.63	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	18.76	0.30	1.51	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	31.65	0.79	1.58	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	21.54	0.00	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	15.40	1.86	1.37	0.62
Myoblast, donor2	11322-117D8	31.26	1.34	1.15	0.96
Myoblast, donor3	11398-118D3	25.90	1.01	1.18	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	31.08	4.82	2.33	0.15
Natural Killer Cells, donor1	11230-116C6	7.07	5.54	5.23	0.00
Natural Killer Cells, donor2	11311-117C6	8.14	5.43	5.73	0.00
Natural Killer Cells, donor3	11387-118C1	6.99	3.13	5.52	0.18
Neural stem cells, donor1	11275-116H6	43.19	2.54	0.36	2.18
Neural stem cells, donor2	11352-117H2	26.96	0.00	0.00	0.00
Neurons, donor1	11494-119E9	29.59	1.14	2.28	0.00
Neurons, donor2	11574-120E8	20.70	4.18	0.66	0.22
Neurons, donor3	11655-122E8	35.35	1.64	1.64	0.00
Neutrophils, donor1	11233-116C9	1.86	1.86	9.28	0.00
Neutrophils, donor2	11314-117C9	8.70	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	1.22	3.05	10.38	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	24.82	1.66	1.66	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	34.84	0.65	2.93	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	39.11	2.81	0.80	0.40
Olfactory epithelial cells, donor1	11933-125I7	16.66	1.38	0.41	0.00
Olfactory epithelial cells, donor2	11934-125I8	23.74	0.43	0.72	0.58
Olfactory epithelial cells, donor3	11935-125I9	22.70	0.34	0.91	0.68
Olfactory epithelial cells, donor4	11936-126A1	16.56	0.58	0.68	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	35.51	1.81	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	12.97	3.83	1.91	0.21
Osteoblast - differentiated, donor2	11353-117H3	18.29	5.72	4.57	0.00
Osteoblast - differentiated, donor3	11425-118G3	14.28	4.97	5.59	1.24
Osteoblast, donor1	11277-116H8	81.30	5.08	2.35	2.74
Osteoblast, donor2	11354-117H4	32.31	0.70	0.00	1.40
Osteoblast, donor3	11426-118G4	47.45	2.13	1.24	0.53
Pancreatic stromal cells, donor1	11249-116E7	28.13	2.02	1.77	0.42
Pericytes, donor1	11491-119E6	46.40	4.78	1.56	0.56
Pericytes, donor2	11571-120E5	39.61	3.40	1.13	0.23
Pericytes, donor3	11652-122E5	32.35	2.24	0.41	0.61
Perineurial Cells, donor1	11499-119F5	23.62	3.28	1.02	0.34
Perineurial Cells, donor2	11579-120F4	29.35	3.59	1.93	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	6.69	6.37	2.23	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	5.39	8.33	2.94	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	3.24	5.18	1.81	0.00
Placental Epithelial Cells, donor1	11278-116H9	15.07	8.37	1.43	0.00
Placental Epithelial Cells, donor2	11355-117H5	24.40	5.54	3.33	1.11
Placental Epithelial Cells, donor3	11427-118G5	28.07	4.52	2.36	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.35	1.27	0.32	0.63
Preadipocyte - breast, donor1	11467-119B9	13.51	0.38	0.19	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	19.71	0.39	0.91	0.26
Preadipocyte - breast, donor2	11328-117E5	18.69	0.90	0.90	0.00
Preadipocyte - omental, donor1	11468-119C1	20.67	1.49	0.75	0.85
Preadipocyte - omental, donor2	11329-117E6	17.02	1.31	0.44	1.31
Preadipocyte - omental, donor3	11403-118D8	22.20	0.29	0.29	0.86
Preadipocyte - perirenal, donor1	11469-119C2	27.56	0.00	2.95	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	52.82	3.38	2.15	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	29.04	3.19	1.06	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	35.93	1.53	0.68	0.51
Preadipocyte - visceral, donor1	11280-116I2	22.63	1.21	0.75	0.37
Preadipocyte - visceral, donor2	11357-117H7	26.23	2.30	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	22.36	1.88	0.84	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	25.64	1.36	0.45	0.45
Prostate Epithelial Cells, donor2	11331-117E8	20.18	1.22	1.35	0.41
Prostate Epithelial Cells, donor3	11404-118D9	8.51	3.37	0.86	0.00
Prostate Stromal Cells, donor1	11254-116F3	36.45	1.37	1.25	2.16
Prostate Stromal Cells, donor2	11332-117E9	41.96	2.51	1.08	1.26
Prostate Stromal Cells, donor3	11405-118E1	25.23	1.36	1.88	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	33.94	6.93	1.46	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	21.69	5.48	0.83	0.14
Renal Epithelial Cells, donor1	11517-119H5	66.45	5.07	2.03	1.52
Renal Epithelial Cells, donor2	11597-120H4	31.30	3.56	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	27.42	3.92	0.95	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	38.81	4.77	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	32.21	3.37	0.81	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	40.18	4.44	1.11	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	51.24	6.65	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	55.46	3.08	1.10	0.22
Renal Mesangial Cells, donor2	11598-120H5	35.74	3.76	4.39	0.00
Renal Mesangial Cells, donor3	11679-122H5	62.42	2.77	2.50	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	25.50	7.52	1.07	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	33.74	4.22	2.11	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	43.78	4.44	1.93	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	19.19	5.44	1.81	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	31.84	1.42	2.56	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	44.25	0.00	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	16.56	6.27	1.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	5.88	5.88	0.80	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	34.84	0.00	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	54.49	1.10	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	34.80	0.00	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	38.49	0.13	0.13	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	38.43	0.89	0.40	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	50.19	0.67	0.56	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	38.21	0.25	0.12	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	45.57	0.58	0.70	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	54.78	0.46	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	30.39	0.41	0.55	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	40.39	0.30	0.45	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	54.47	1.08	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	34.29	0.29	0.43	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	38.53	0.64	0.32	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	43.81	0.44	0.44	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	27.91	0.96	0.57	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	35.50	0.47	0.28	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	36.64	0.38	0.19	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	31.19	0.40	0.00	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	37.48	0.49	0.29	1.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	45.45	0.57	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	30.86	0.32	0.11	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	37.56	1.12	0.84	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	42.21	0.34	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	28.08	0.18	0.55	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	37.16	0.37	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	44.19	0.54	0.67	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	36.09	0.71	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	37.50	0.40	0.20	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	47.70	0.23	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	32.35	1.24	0.21	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	35.61	1.11	0.88	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	40.31	0.84	0.21	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	29.88	0.67	0.40	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	36.44	0.85	0.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	40.87	0.58	0.19	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	32.84	0.52	0.17	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	34.43	0.69	1.10	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	43.50	0.16	0.66	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	33.57	0.00	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	41.58	0.74	0.15	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	40.25	0.53	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	34.70	0.69	0.41	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	38.57	0.48	0.00	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	41.32	1.01	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	31.17	0.38	0.57	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	36.33	1.40	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	35.66	1.51	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	26.07	0.73	0.12	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	39.15	2.33	0.87	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	52.32	1.83	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	29.54	0.30	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	42.07	1.81	0.90	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	44.93	1.80	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	40.38	0.47	0.35	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	45.46	1.07	0.43	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	43.27	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	44.76	5.27	2.07	1.13
Schwann Cells, donor2	11578-120F3	20.41	3.40	3.40	3.40
Schwann Cells, donor3	11659-122F3	34.83	1.97	0.88	0.22
Sebocyte, donor1	11220-116B5	31.22	3.29	0.55	0.55
Sebocyte, donor2	11301-117B5	41.82	2.30	0.00	0.92
Sebocyte, donor3	11378-118B1	16.28	2.47	0.41	0.00
Sertoli Cells, donor1	11255-116F4	13.25	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	5.65	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	47.42	5.10	3.17	1.06
Skeletal Muscle Cells, donor2	11358-117H8	55.66	3.61	5.06	2.89
Skeletal Muscle Cells, donor3	11430-118G8	80.26	5.85	1.67	1.67
Skeletal Muscle Cells, donor4	11451-119A2	33.93	3.14	0.47	0.79
Skeletal Muscle Cells, donor5	11455-119A6	32.40	1.93	0.74	0.15
Skeletal Muscle Cells, donor6	11459-119B1	32.94	3.39	0.15	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	41.58	3.02	1.89	1.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	42.09	3.42	1.28	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	30.26	3.47	1.09	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	42.04	1.52	1.94	1.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	58.62	5.79	2.17	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	48.57	1.93	2.20	1.24
Skin - palm, donor1	10286-104F7	0.00	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	25.66	1.30	1.59	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	84.24	2.45	2.45	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	29.47	3.38	0.52	1.04
Small Airway Epithelial Cells, donor1	11256-116F5	32.53	5.00	0.97	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	35.02	3.09	2.11	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	38.48	2.75	2.33	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	17.01	4.95	1.20	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	20.98	1.23	0.93	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	15.34	0.89	0.22	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	28.22	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	19.23	3.31	1.33	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	34.65	2.36	0.79	2.76
Smooth Muscle Cells - Aortic, donor3	11432-118H1	37.08	1.55	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	43.03	6.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	22.22	2.40	1.06	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	20.61	1.11	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	26.76	1.66	1.15	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.65	3.91	1.30	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	31.30	1.48	0.89	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	24.49	0.85	0.43	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	37.25	1.63	0.33	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	27.70	1.52	2.13	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	26.01	4.80	4.55	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	24.32	4.77	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	30.38	0.74	0.59	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	30.35	0.65	0.86	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	32.33	1.05	0.73	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	34.80	2.63	0.62	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	33.41	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	28.09	1.79	1.20	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	51.89	3.07	0.34	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	32.04	1.81	0.55	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.56	1.51	1.11	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	39.14	0.68	0.91	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	38.04	1.81	0.60	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	25.17	2.91	1.06	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	29.03	1.46	0.53	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	51.21	1.00	1.63	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	16.23	1.27	2.03	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	26.08	2.26	1.81	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.76	3.75	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	16.80	1.29	1.29	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	46.97	2.33	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	25.75	2.02	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	17.24	1.88	0.63	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	16.22	1.77	0.88	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	32.57	2.67	1.50	0.67
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	34.57	0.93	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	20.00	3.02	1.44	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	34.16	2.80	0.76	1.53
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	35.54	2.82	0.56	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	30.05	2.52	0.70	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	35.86	2.01	1.01	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	27.14	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	15.90	2.20	0.98	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	24.97	0.44	0.44	1.33
Smooth Muscle Cells - Uterine, donor3	11466-119B8	23.70	2.05	2.93	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	28.77	1.36	2.14	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	19.57	0.79	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	37.94	1.12	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	19.76	2.52	0.72	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	21.01	0.28	0.85	1.70
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	24.81	1.58	0.39	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	20.82	0.76	1.02	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	20.76	0.40	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	18.81	0.00	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	28.88	2.75	1.83	1.83
Synoviocyte, donor1	11291-117A4	17.67	1.35	0.50	0.34
Synoviocyte, donor2	11368-117I9	13.75	2.01	1.51	0.17
Synoviocyte, donor3	11440-118H9	10.95	2.68	1.12	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	43.24	1.79	1.43	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	61.44	13.87	3.96	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	54.88	3.01	1.62	1.62
Tracheal Epithelial Cells, donor1	11292-117A5	34.84	3.51	0.72	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	37.11	6.57	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	33.21	5.15	2.29	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	6.89	5.29	0.37	0.00
Urethra, donor2	10319-105A4	7.19	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	31.08	3.45	0.80	1.06
Urothelial Cells, donor2	11600-120H7	27.24	4.01	1.20	0.00
Urothelial Cells, donor3	11681-122H7	23.15	4.58	0.92	0.23
Urothelial cells, donor0	11216-116B1	21.40	3.34	1.11	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	3.56	17.80	2.67	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	5.72	22.87	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	9.58	15.74	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	10.67	13.08	2.75	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	6.97	15.69	2.91	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	12.49	11.45	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	2.75	15.60	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	9.13	5.48	2.74	0.00
Wilms' tumor cell line:G-401	10809-111A8	77.84	1.11	2.47	3.08
Wilms' tumor cell line:HFWT	10597-108E3	13.20	0.88	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	19.83	3.35	1.68	0.00
achilles tendon, donor2	10292-104G4	2.07	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	75.47	1.53	1.27	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	25.54	4.88	2.55	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	33.71	2.61	1.19	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	48.16	1.36	1.36	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	43.85	1.69	0.84	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	98.76	2.11	6.13	1.69
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	69.14	1.91	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	77.11	0.88	0.88	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	66.97	0.82	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	32.23	2.72	2.33	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	46.74	0.74	1.10	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	15.60	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	93.88	1.16	3.25	2.09
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	42.72	7.51	3.11	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	23.67	2.92	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	10.69	3.25	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	47.71	0.00	1.65	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	73.67	6.14	2.76	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	55.05	4.27	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	60.96	4.85	4.25	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	69.32	5.30	2.41	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	41.43	1.34	1.11	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	20.35	6.00	3.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	137.51	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	155.94	3.39	0.38	2.64
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	28.35	1.31	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	59.98	3.75	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	13.42	5.42	1.65	0.00
adipose tissue, adult, pool1	10010-101C1	5.89	6.83	1.86	0.00
adipose, donor1	10184-103D4	66.26	17.59	7.04	1.76
adipose, donor2	10185-103D5	29.60	5.68	2.84	2.03
adipose, donor3	10186-103D6	48.20	9.53	3.81	2.72
adipose, donor4	10187-103D7	29.47	5.20	2.60	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	26.99	8.21	2.21	1.10
adrenal gland, adult, pool1	10081-102A9	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	27.21	4.40	2.80	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	10.00	3.57	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	2.78	2.32	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	10.82	4.73	1.69	0.34
amniotic membrane cells, donor3	12237-129G5	3.83	3.24	1.47	0.00
amygdala - adult, donor10196	10167-103B5	5.93	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	10.54	2.43	0.41	0.00
amygdala, newborn, donor10223	10360-105E9	8.39	2.26	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	50.04	3.95	2.42	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	42.80	2.65	0.66	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	59.46	0.00	0.67	0.67
aorta, adult, pool1	10052-101G7	4.90	3.33	0.98	0.00
appendix, adult	10189-103D9	20.96	1.94	2.33	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	27.86	3.78	1.72	0.00
artery, adult	10190-103E1	17.66	6.79	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	28.54	0.58	0.58	0.87
b cell line:RPMI1788	10427-106D4	20.82	1.04	0.74	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	15.26	1.66	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	18.26	1.49	0.69	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	5.36	2.34	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	51.45	12.86	13.42	1.12
bladder, adult, pool1	10011-101C2	6.63	5.98	1.20	0.00
blood, adult, pool1	10053-101G8	11.07	8.86	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	31.68	0.00	0.86	0.00
bone marrow, adult	10192-103E3	23.62	1.35	1.35	0.00
brain, adult, donor1	10084-102B3	11.28	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	8.35	2.00	0.89	0.33
brain, fetal, pool1	10085-102B4	16.03	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	11.89	4.63	4.96	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	34.20	4.24	1.87	0.12
breast, adult, donor1	10080-102A8	5.05	3.79	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	16.26	4.70	0.13	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	12.99	0.62	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	14.73	3.45	0.92	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	31.71	3.63	1.69	0.00
carcinoid cell line:NCI-H1770	10703-109H1	30.56	0.47	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	20.34	7.44	3.94	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	29.15	0.95	0.32	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	37.53	4.26	0.27	0.27
caudate nucleus - adult, donor10196	10177-103C6	5.76	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	12.55	3.35	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	6.88	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	14.65	3.66	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	11.65	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	3.42	5.34	0.64	0.00
cerebellum, adult, pool1	10083-102B2	5.17	2.76	0.34	0.69
cerebellum, newborn, donor10223	10357-105E6	14.95	7.47	0.00	0.00
cerebral meninges, adult	10188-103D8	10.59	0.50	1.26	0.00
cerebrospinal fluid, donor2	10294-104G6	3.65	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	18.12	5.61	1.44	0.00
cervical cancer cell line:ME-180	10553-107I4	35.79	3.31	1.99	0.17
cervix, adult, pool1	10013-101C4	15.96	6.93	0.84	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	30.65	3.76	1.25	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	19.59	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	13.42	11.31	2.86	0.00
choriocarcinoma cell line:SCH	10785-110H2	25.38	7.02	2.59	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	1.19	6.17	0.95	0.00
chorionic membrane cells, donor1	12238-129G6	5.70	5.98	1.14	0.00
chorionic membrane cells, donor2	12239-129G7	28.44	1.99	1.19	0.20
chorionic membrane cells, donor3	12240-129G8	4.95	6.59	3.30	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	36.35	1.01	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	25.36	2.31	0.96	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	57.86	3.17	1.48	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	40.32	2.31	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	42.57	2.90	2.90	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	49.88	2.85	1.83	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	74.50	1.77	1.18	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	46.39	4.69	2.35	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	12.80	3.43	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	8.85	1.91	1.39	0.00
colon carcinoma cell line:CACO-2	10513-107D9	16.47	2.01	1.10	0.55
colon carcinoma cell line:COLO-320	10420-106C6	24.71	3.42	2.66	0.38
colon, adult, donor1	10082-102B1	15.47	3.57	0.00	0.00
colon, adult, pool1	10014-101C5	11.63	9.75	1.29	0.00
colon, fetal, donor1	10070-101I7	2.47	1.24	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	73.34	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	12.75	0.85	1.27	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	21.73	2.87	2.87	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	22.42	2.82	1.97	0.14
corpus callosum, adult, pool1	10042-101F6	14.48	5.42	0.66	0.11
cruciate ligament, donor2	10295-104G7	4.86	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	23.27	1.61	0.00	0.00
diencephalon, adult	10193-103E4	8.40	3.12	0.48	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	59.70	3.44	2.53	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	14.10	4.10	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	26.96	1.93	0.96	0.24
ductus deferens, adult	10196-103E7	12.96	4.98	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	8.64	4.32	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	16.92	3.68	0.74	1.47
dura mater, adult, donor1	10041-101F5	8.42	3.30	3.22	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	24.43	19.76	7.99	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	17.91	6.16	1.86	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	16.03	1.85	1.85	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	19.68	2.42	2.42	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	16.67	2.16	2.16	0.00
embryonic pancreas cell line:2C6	10603-108E9	28.90	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	34.53	1.34	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	25.74	4.17	3.08	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	18.33	2.89	1.61	0.00
epidermoid carcinoma cell line:A431	10426-106D3	18.23	1.45	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	27.06	4.40	0.66	0.33
epididymis, adult	10197-103E8	15.07	4.19	2.09	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	39.92	2.48	2.31	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	34.61	1.57	0.79	2.75
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	47.44	3.41	0.66	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	32.38	2.36	0.89	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	44.70	3.25	1.34	0.56
esophagus, adult, pool1	10015-101C6	7.54	9.03	1.59	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	21.16	11.15	4.51	0.00
eye - muscle inferior rectus, donor1	10272-104E2	12.07	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	14.73	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	13.39	0.00	2.98	0.00
eye - muscle superior, donor2	10297-104G9	5.73	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	20.40	2.91	1.46	1.46
eye, fetal, donor1	10054-101G9	9.41	9.41	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	24.11	0.38	1.03	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	24.69	1.66	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	8.91	2.44	1.03	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	60.65	2.70	1.50	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	12.98	1.65	0.64	0.09
gall bladder, adult	10198-103E9	6.28	5.31	0.97	0.00
gamma delta positive T cells, donor1	11937-126A2	27.92	8.05	5.91	0.00
gamma delta positive T cells, donor2	11938-126A3	23.16	5.23	2.61	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	45.20	1.69	2.11	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	28.82	5.61	1.93	0.00
gastric cancer cell line:AZ521	10549-107H9	59.35	8.03	2.30	1.97
gastric cancer cell line:GSS	10560-108A2	10.98	11.90	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	36.55	5.71	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	3.79	3.44	0.92	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	11.76	4.34	0.84	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	11.97	2.74	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	38.21	1.06	0.74	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	34.69	1.54	1.97	0.98
glioblastoma cell line:T98G	10485-107A8	26.82	1.77	1.10	0.99
glioma cell line:GI-1	10413-106B8	25.48	3.22	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	11.66	1.46	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	10.25	6.35	1.22	0.00
globus pallidus, adult, donor10258	10367-105F7	16.43	4.11	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	14.39	2.66	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	53.84	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	18.56	0.32	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	51.42	4.13	0.92	2.30
hIPS +CCl2, biol_rep2	14384-156C1	40.70	1.37	0.00	3.20
hIPS +CCl2, biol_rep3	14385-156C2	58.61	1.29	1.29	3.22
hIPS, biol_rep1	14380-156B6	54.62	1.44	0.00	1.44
hIPS, biol_rep2	14381-156B7	58.98	4.12	2.06	4.80
hIPS, biol_rep3	14382-156B8	17.66	3.31	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	20.40	4.60	3.74	0.00
heart - mitral valve, adult	10205-103F7	6.58	2.99	0.30	0.30
heart - pulmonic valve, adult	10206-103F8	8.11	2.35	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	4.16	1.67	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	12.24	4.29	1.22	0.00
heart, adult, diseased, donor1	10051-101G6	8.09	3.83	0.43	0.00
heart, adult, pool1	10016-101C7	9.89	5.52	1.38	0.23
heart, fetal, pool1	10046-101G1	21.77	2.77	0.62	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.12	0.00	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	4.76	7.14	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	26.74	2.21	0.77	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	29.25	2.67	0.61	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	24.66	1.82	0.30	0.61
hepatoma cell line:Li-7	10484-107A7	34.48	1.11	0.67	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	41.71	0.80	1.61	1.01
hippocampus - adult, donor10196	10169-103B7	6.62	2.84	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	14.29	5.71	1.02	0.00
hippocampus, adult, donor10258	10374-105G5	4.98	1.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	5.64	2.11	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	61.64	14.65	1.83	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	37.50	6.87	2.36	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	40.12	6.86	3.30	3.30
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	69.36	12.97	2.26	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	60.94	14.46	1.81	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	64.15	14.80	2.66	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	71.24	6.13	1.75	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	66.78	3.88	3.23	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	58.39	5.84	2.92	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	76.72	5.45	4.50	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	66.86	7.23	3.05	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	88.20	6.06	2.02	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	32.86	4.23	1.41	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	39.79	6.39	1.47	3.93
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	70.69	5.24	3.49	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	48.30	9.35	2.48	1.91
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	41.43	15.26	2.62	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	53.47	18.99	4.00	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	30.52	9.98	3.96	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	34.10	11.82	1.82	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	38.53	11.90	4.39	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	38.87	10.29	2.61	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	40.93	9.29	2.90	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	49.92	14.35	3.29	2.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	49.51	5.54	2.40	1.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	44.79	3.71	1.14	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	86.97	6.94	5.31	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	55.98	12.32	2.46	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	46.88	8.24	1.58	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	73.23	15.74	3.93	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	33.10	9.83	2.59	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	47.82	6.64	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	53.87	10.52	3.08	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	42.95	7.93	0.77	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	51.49	13.63	2.27	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	69.23	8.07	2.02	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	43.71	5.80	1.21	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	69.97	8.91	1.78	4.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	65.37	6.34	1.46	2.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	66.62	11.31	3.36	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	126.88	9.76	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	103.92	15.55	5.96	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	64.58	6.02	1.64	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	70.57	5.43	2.53	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	86.48	7.47	3.91	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	60.86	9.55	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	74.21	10.02	2.44	1.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	64.65	9.43	1.62	3.50
immature langerhans cells, donor1	11904-125F5	7.26	1.70	5.33	0.24
immature langerhans cells, donor2	11905-125F6	7.13	1.58	7.13	0.00
insula, adult, pool1	10039-101F3	10.03	1.99	0.47	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	19.18	1.63	3.25	0.00
kidney, adult, pool1	10017-101C8	11.41	5.31	1.20	0.00
kidney, fetal, pool1	10045-101F9	25.11	6.79	0.85	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	28.55	1.56	1.42	1.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	15.62	1.24	1.24	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	11.74	2.02	1.47	0.00
left atrium, adult, donor1	10079-102A7	10.90	2.72	0.54	0.00
left ventricle, adult, donor1	10078-102A6	5.06	3.54	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	52.81	0.27	1.37	2.46
leiomyoma cell line:10964C	10569-108B2	16.53	1.08	2.16	0.72
leiomyoma cell line:15242A	10570-108B3	15.22	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	16.27	0.49	0.73	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	26.14	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	77.45	2.95	0.47	0.35
liposarcoma cell line:KMLS-1	10782-110G8	17.34	3.75	1.72	0.16
liposarcoma cell line:SW 872	10726-110A6	31.56	0.24	1.10	0.49
liver, adult, pool1	10018-101C9	4.70	3.24	0.65	0.00
liver, fetal, pool1	10086-102B5	3.76	6.58	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	7.00	3.06	0.44	0.15
locus coeruleus, adult, donor10252	10165-103B3	13.10	2.95	1.11	0.18
locus coeruleus, adult, donor10258	10375-105G6	18.06	2.26	0.56	0.85
locus coeruleus, newborn, donor10223	10362-105F2	18.93	2.52	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	4.15	3.04	0.83	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	57.22	1.38	3.45	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	12.39	3.69	1.19	0.13
lung, adult, pool1	10019-101D1	9.45	5.08	0.71	0.00
lung, fetal, donor1	10068-101I5	21.12	6.56	0.86	0.00
lung, right lower lobe, adult, donor1	10075-102A3	7.79	4.58	0.92	0.00
lymph node, adult, donor1	10077-102A5	13.25	2.84	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	32.44	2.19	1.75	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	54.33	1.06	2.72	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	11.89	1.70	0.00	0.00
mature adipocyte, donor1	12231-129F8	7.55	0.44	1.33	0.00
mature adipocyte, donor2	12232-129F9	11.62	2.49	1.25	0.21
mature adipocyte, donor3	12233-129G1	6.40	1.90	1.19	0.00
mature adipocyte, donor4	12234-129G2	8.69	3.69	0.79	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	10.25	7.15	1.67	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	9.93	3.31	0.74	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	6.04	1.91	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	12.79	0.85	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	8.44	1.69	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	11.25	1.91	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	5.78	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	7.90	1.79	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	6.49	3.24	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	7.59	4.49	0.93	0.00
medulla oblongata, adult, pool1	10038-101F2	11.43	2.69	1.55	0.16
medulla oblongata, newborn, donor10223	10361-105F1	17.36	6.60	0.00	0.69
medulloblastoma cell line:D283 Med	10838-111E1	15.94	9.08	1.99	0.66
medulloblastoma cell line:ONS-76	10759-110E3	50.38	3.06	0.37	0.61
melanoma cell line:COLO 679	10514-107E1	21.56	2.01	1.87	0.00
melanoma cell line:G-361	10465-106H6	21.45	4.61	2.17	0.27
meningioma cell line:HKBMM	10691-109F7	11.94	2.89	1.09	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	41.41	4.41	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	33.70	2.07	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	28.08	0.77	1.53	1.38
mesenchymal precursor cell - adipose, donor2	11748-123G2	37.63	0.55	1.64	1.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	24.02	2.07	3.31	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	12.78	0.42	0.42	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.49	0.39	0.58	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	15.96	1.39	2.78	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	18.19	2.06	1.03	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	16.33	0.69	1.15	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	24.94	1.19	0.53	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.42	0.81	1.08	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	21.34	0.28	0.43	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	13.50	2.31	1.98	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	29.61	0.69	0.97	1.11
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	24.09	1.75	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	21.03	0.41	0.82	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.85	1.08	0.00	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.55	0.72	0.21	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	12.54	0.91	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	17.62	0.42	0.42	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	19.28	0.15	1.49	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	31.42	0.61	1.31	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.83	0.37	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	21.46	0.86	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	32.42	2.11	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	32.42	1.37	1.83	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	31.72	1.02	2.05	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	35.60	1.31	1.31	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	25.88	1.23	0.92	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	28.48	1.18	1.41	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	33.85	2.71	1.35	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	30.65	1.96	1.96	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	34.29	1.39	2.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	40.38	2.02	1.73	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	33.47	2.45	0.45	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	30.04	1.92	1.44	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	38.13	2.20	0.00	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	33.57	1.34	1.34	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	34.80	1.64	1.64	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	32.22	0.00	1.72	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	46.48	2.73	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	0.00	5.16	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	32.48	1.30	1.30	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	30.55	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	34.12	0.53	2.67	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.08	0.82	1.64	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	25.27	0.39	1.17	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	29.38	2.10	2.10	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	22.85	0.99	2.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	31.43	1.78	1.19	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.67	2.53	1.90	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	21.38	1.03	3.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	34.39	6.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	43.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	30.15	2.44	2.44	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	24.63	3.18	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.99	4.72	1.77	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	20.57	1.25	2.49	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	32.08	1.34	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	30.75	1.18	1.18	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	30.29	2.07	2.07	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	28.20	3.46	0.49	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	29.16	1.12	1.12	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	36.89	3.18	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	31.03	2.82	1.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	39.25	10.90	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	34.21	3.80	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	16.99	6.68	1.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	13.56	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	19.77	5.77	4.94	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	21.63	0.99	2.58	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	20.12	1.95	1.30	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	21.39	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.99	0.00	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	17.72	7.09	1.42	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	30.12	0.00	0.70	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	74.49	4.01	1.44	1.13
mesothelioma cell line:Mero-25	10850-111F4	48.80	1.59	0.68	0.68
mesothelioma cell line:Mero-41	10851-111F5	44.01	1.22	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	20.59	0.89	0.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	31.27	2.63	0.26	1.84
mesothelioma cell line:Mero-83	10854-111F8	29.28	0.51	0.68	1.19
mesothelioma cell line:Mero-84	10855-111F9	33.62	1.26	0.25	1.26
mesothelioma cell line:Mero-95	10856-111G1	26.29	0.83	1.66	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	12.26	3.81	0.99	0.00
mesothelioma cell line:NCI-H226	10846-111E9	31.13	0.72	0.72	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	21.52	2.73	1.71	0.85
mesothelioma cell line:NCI-H28	10845-111E8	21.38	2.80	1.27	0.00
mesothelioma cell line:No36	10857-111G2	8.48	2.61	2.94	0.33
mesothelioma cell line:ONE58	10858-111G3	15.17	2.98	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	8.83	2.30	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	8.18	5.25	1.47	0.12
migratory langerhans cells, donor3	11903-125F4	15.61	1.97	1.62	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	47.99	2.61	2.29	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	23.10	0.00	0.64	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	19.35	1.61	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	24.74	4.57	1.52	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	42.50	7.39	1.66	0.00
myeloma cell line:PCM6	10474-106I6	58.11	2.97	3.56	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	28.41	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.42	4.12	1.18	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	16.71	6.13	2.56	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	15.96	8.46	1.62	0.15
nasal epithelial cells, donor2	12227-129F4	15.46	2.76	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	19.10	3.91	4.60	0.00
neuroblastoma cell line:NB-1	10539-107G8	38.91	2.43	0.94	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	69.59	4.01	0.84	2.11
neuroblastoma cell line:NH-12	10555-107I6	13.42	5.59	2.42	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	47.21	1.90	0.95	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	65.73	4.43	2.22	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	72.45	1.81	1.41	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	56.58	1.27	1.91	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	23.69	0.27	0.00	0.27
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	26.56	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	27.74	1.35	0.85	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	19.21	9.61	3.20	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	37.83	0.32	0.96	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	50.19	1.05	1.31	0.26
nucleus accumbens, adult, pool1	10037-101F1	8.44	2.34	0.37	0.09
occipital cortex - adult, donor10196	10172-103C1	2.06	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	8.32	5.10	0.54	0.00
occipital cortex, newborn, donor10223	10355-105E4	6.55	2.18	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	5.77	1.31	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	11.59	0.86	0.00	0.00
occipital pole, adult, pool1	10036-101E9	7.49	2.21	0.87	0.08
olfactory region, adult	10195-103E6	7.26	1.91	0.96	0.00
optic nerve, donor1	10277-104E7	4.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	37.59	7.29	2.51	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	17.86	1.24	0.55	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.58	1.86	0.85	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	16.17	1.73	0.69	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	16.76	0.88	0.88	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	22.42	4.67	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	44.32	1.48	0.85	1.27
ovary, adult, pool1	10020-101D2	11.79	3.76	2.45	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	30.98	1.10	0.00	1.47
pancreas, adult, donor1	10049-101G4	9.41	4.70	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	8.67	14.82	5.31	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	15.50	3.41	1.19	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	21.69	2.65	0.33	0.17
paracentral gyrus, adult, pool1	10035-101E8	8.69	1.65	0.55	0.00
parietal cortex, adult, donor10258	10373-105G4	5.87	1.47	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	5.64	1.88	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	6.27	7.13	1.14	0.00
parietal lobe, adult, pool1	10034-101E7	10.05	2.38	1.06	0.18
parietal lobe, fetal, donor1	10072-101I9	10.67	3.88	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	6.73	2.24	0.37	0.00
parotid gland, adult	10199-103F1	25.28	7.40	1.23	0.00
penis, adult	10200-103F2	6.98	3.22	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	23.24	2.97	0.93	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	29.58	1.17	1.17	0.44
pineal gland - adult, donor10196	10179-103C8	3.87	1.29	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	6.51	3.55	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	8.78	5.64	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	11.13	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	16.16	2.61	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	10.21	7.66	0.85	0.00
placenta, adult, pool1	10021-101D3	9.25	8.28	2.15	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	35.23	2.38	1.32	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	6.85	1.40	0.31	0.00
pons, adult, pool1	10033-101E6	6.11	2.67	1.29	0.09
postcentral gyrus, adult, pool1	10032-101E5	7.24	2.35	1.31	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	33.46	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	22.03	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	70.41	23.47	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	13.98	6.85	2.62	0.15
prostate cancer cell line:PC-3	10439-106E7	53.72	3.09	1.09	1.45
prostate, adult, pool1	10022-101D4	9.61	7.53	0.91	0.00
putamen, adult, donor10196	10176-103C5	9.91	2.60	1.42	0.00
putamen, adult, donor10252	10152-102I8	11.76	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	20.76	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	8.70	1.69	1.21	0.24
putamen, newborn, donor10223	10365-105F5	16.49	1.50	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	18.62	4.07	0.00	0.29
rectum, fetal, donor1	10067-101I4	19.47	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	18.44	1.70	1.06	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	4.56	2.07	0.00	0.00
retina, adult, pool1	10030-101E3	11.63	6.26	2.48	0.00
retinoblastoma cell line:Y79	10475-106I7	18.19	0.78	3.12	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	44.63	1.72	1.97	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	123.45	4.22	3.09	3.37
sacrococcigeal teratoma cell line:HTST	10695-109G2	24.25	1.52	2.27	0.76
salivary acinar cells, donor1	11771-123I7	14.24	2.43	2.27	0.00
salivary acinar cells, donor2	11772-123I8	13.63	3.99	2.48	0.41
salivary acinar cells, donor3	11773-123I9	10.59	3.97	0.00	0.00
salivary gland, adult, pool1	10093-102C3	10.30	16.01	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	29.68	3.29	2.19	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	29.15	3.88	4.11	0.00
seminal vesicle, adult	10201-103F3	16.40	6.35	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	15.30	3.16	1.70	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	26.92	4.03	2.52	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	31.11	13.05	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	11.82	7.66	1.88	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	8.62	1.88	0.66	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	5.42	2.71	1.94	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	29.79	0.00	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	18.35	4.32	2.04	0.12
skeletal muscle, fetal, donor1	10066-101I3	36.18	1.01	3.02	1.01
skin, adult, donor1	10074-102A2	0.00	13.57	6.79	0.00
skin, fetal, donor1	10065-101I2	19.57	1.89	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	36.35	3.34	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	52.32	6.93	2.21	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	55.51	5.59	2.12	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	21.26	8.24	2.31	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	10.62	10.62	2.41	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	23.10	3.05	0.65	0.22
small intestine, adult, pool1	10024-101D6	8.00	8.84	1.91	0.12
small intestine, fetal, donor1	10064-101I1	16.71	4.18	1.47	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	8.72	3.08	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	4.91	4.91	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	4.56	4.29	0.80	0.27
spinal cord - adult, donor10196	10181-103D1	7.57	2.52	0.23	0.46
spinal cord, adult, donor10252	10159-103A6	6.70	2.76	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	26.98	2.77	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	31.10	4.88	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	26.63	6.89	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	26.44	0.30	0.45	0.45
spleen, adult, pool1	10025-101D7	18.28	5.29	1.76	0.11
spleen, fetal, pool1	10044-101F8	24.55	5.88	1.03	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	39.13	3.00	2.79	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.77	0.57	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	12.58	7.69	2.10	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	19.16	3.52	1.95	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	2.25	1.46	1.24	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	30.92	0.85	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	21.15	0.42	0.00	0.85
stomach, fetal, donor1	10062-101H8	12.82	4.27	1.07	0.00
submaxillary gland, adult	10202-103F4	11.39	10.25	2.85	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	9.76	7.06	1.04	0.21
substantia nigra, adult, donor10258	10371-105G2	17.59	3.10	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	14.84	2.12	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	61.21	3.67	3.44	1.60
temporal lobe, adult, pool1	10031-101E4	11.10	2.88	1.02	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	11.40	0.00	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	16.26	2.20	0.44	0.44
tenocyte, donor1	11763-123H8	25.83	3.84	1.05	0.35
tenocyte, donor2	11765-123I1	18.31	1.91	0.76	0.00
tenocyte, donor3	11768-123I4	22.61	2.59	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	11.39	7.99	1.19	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	30.52	2.62	0.92	0.77
teratocarcinoma cell line:PA-1	10807-111A6	11.47	4.65	0.31	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	4.70	3.43	1.78	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	4.16	11.35	3.40	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	2.07	8.51	3.82	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	1.30	6.84	0.98	0.00
testis, adult, pool1	10026-101D8	8.91	2.90	1.61	0.11
testis, adult, pool2	10096-102C6	6.77	1.80	1.35	0.00
thalamus - adult, donor10196	10168-103B6	4.42	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	5.78	5.78	0.47	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	4.62	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.87	4.28	0.99	0.66
thalamus, newborn, donor10223	10366-105F6	13.23	2.30	0.00	0.00
throat, adult	10209-103G2	16.23	6.24	1.75	0.00
throat, fetal, donor1	10061-101H7	30.78	3.66	0.61	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	73.53	0.40	0.79	1.19
thymus, adult, pool1	10027-101D9	45.33	6.16	2.09	0.00
thymus, fetal, pool1	10043-101F7	32.52	4.68	1.66	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	21.67	5.19	0.80	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	38.55	3.63	1.12	0.70
thyroid, adult, pool1	10028-101E1	32.57	7.09	1.87	0.09
thyroid, fetal, donor1	10060-101H6	25.58	5.01	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	3.08	0.00	0.00
tongue, adult	10203-103F5	11.40	6.05	0.93	0.70
tongue, fetal, donor1	10059-101H5	21.28	3.94	0.39	0.79
tonsil, adult, pool1	10047-101G2	18.13	8.11	2.20	0.00
trachea, adult, pool1	10029-101E2	14.64	6.05	1.96	0.08
trachea, fetal, donor1	10058-101H4	19.23	2.31	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	30.82	0.71	0.71	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	47.31	2.13	1.42	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	64.24	2.98	1.41	1.88
tridermal teratoma cell line:HGRT	10694-109G1	30.44	3.81	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	16.76	4.49	1.61	0.00
umbilical cord, fetal, donor1	10057-101H3	10.43	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	12.29	5.97	0.17	0.34
uterus, fetal, donor1	10055-101H1	25.08	3.58	0.00	1.02
vagina, adult	10204-103F6	1.94	5.17	0.65	0.00
vein, adult	10191-103E2	16.22	4.38	1.53	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	33.11	3.74	2.94	0.00